|
I. S. Dyagil
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical
Sciences of Ukraine», 53 Yuriia Illienka Street, Kyiv, 04050, Ukraine
CHRONIC MYELOID LEUKEMIA – FROM HOPELESSNESS TO SUCCESS IN TREATMENT THE EXPERIENCE OF THE NNCRM AND THE WORLD RECOGNITION OF THE ACHIEVEMENTS OF UKRAINIAN HEMATOLOGISTS
Since 2001, the Department of Radiation OncoA
hematology and Stem Cell Transplantation of
the National Research Center for Radiation MediA
cine, headed by MD, Dr Med. Sci., Prof. Iryna
Dyagil carry on with the problem of chronic myeloid
leukemia (CML), which until 2000 was considered
an incurable disease. Diagnosis and treatment were
limited, and therefore the survival of such patients
was only 3–5 years. In 2001, targeted drugs of tyroA
sine kinase inhibitors were registered (TKI) in the
world, and a rapid development in both diagnosis
and treatment of this disease began. And already the
first data showed impressive results of treatment,
which allowed 85 % of patients with CML to survive,
live and, having achieved a deep molecular remisA
sion, be healthy.
Problems of Radiation Medicine and Radiobiology.
2023;28:549-553. doi: 10.33145/2304-8336-2023-28-549-553
 full text
|
